Skip to main content
. 2018 Aug 13;8:12076. doi: 10.1038/s41598-018-30510-w

Figure 1.

Figure 1

Non-metric multi-dimensional scaling (NMDS) plot illustrating the chicken cecal microbiota beta-diversity of all groups (PBS-treated, C. jejuni-challenged (CC) chickens, low (ECpGL) and high dose (ECpGH) of PLGA-encapsulated CpG-ODN-treated, low (LL) and high dose (LH) of C. jejuni lysate-treated, and unchallenged control (UC) chickens). Chickens were treated orally at 14 days post-hatch with a low (5 µg) or high dose (25 µg) of encapsulated CpG ODN, or a low or high dose of C. jejuni lysate, or received PBS as a placebo, and were orally challenged with 107 CFUs of C. jejuni at 15 days post-hatch. At 22 days post-challenge with C. jejuni, chickens were necropsied and cecal contents were collected for analysis. P < 0.05 was considered significant.